title: Autoantibodies targeting tumor-associated antigens in metastatic cancer: Sialylated IgGs as candidate anti-inflammatory antibodies.
abstract: In addition to the well-established effector functions of IgGs, including direct cytotoxicity and antibody-dependent cellular cytotoxicity, some populations of IgGs may exert anti-inflammatory effects. Here, we describe a population of antibodies that form in the natural course of metastatic cancer and contain glycans that terminate with sialic acid. We demonstrate that both the titer of these antibodies and their level of sialylation are relatively stable throughout the progression of metastatic melanoma. The sialylation pattern of these antibodies somehow correlates with their specificity for tumor-associated antigens, as IgGs targeting several antigens associated with infectious agents are relatively poor of sialic acid. We also show that some antibodies targeting the melanoma-associated antigen NY-ESO-1 bind to the human C-type lectin CD209 (DC-SIGN). We propose that these antibodies are candidate anti-inflammatory antibodies. The presence of anti-inflammatory antibodies in cancer patients may explain, at least in part, why tumors persist and spread in the host despite strong tumor-specific humoral responses. The elucidation of the cellular and molecular pathways involved in the induction of anti-inflammatory antibodies specific for tumor-associated antigens and their function may yield important insights into how tumors evade immune detection and progress.
authors.affiliation: Aurora St. Luke's Medical Center and the Aurora Research Institute; Milwaukee, WI USA.
authors.forename: Martin
authors.initials: M
authors.lastname: Oaks
authors.forename: Samuel
authors.initials: S
authors.lastname: Taylor
authors.forename: James
authors.initials: J
authors.lastname: Shaffer
keywords: DC-SIGN; HER-2/neu; IgG; NY-ESO-1; anti-inflammatory; glycosylation; sialic acid; tumor immunity
references.citation: Arthritis Rheum. 2011 Jul;63(7):2105-15
references.pmid: 21437874
references.citation: J Exp Med. 2007 Jan 22;204(1):11-5
references.pmid: 17227911
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19571-8
references.pmid: 19036920
references.citation: Annu Rev Immunol. 2011;29:235-71
references.pmid: 21219185
references.citation: Curr Pharm Des. 2011;17(29):3166-75
references.pmid: 21864262
references.citation: Ann N Y Acad Sci. 2012 Apr;1253:170-80
references.pmid: 22288459
references.citation: Clin Cancer Res. 2004 Jul 1;10(13):4332-41
references.pmid: 15240519
references.citation: Cancer Res. 2003 Sep 15;63(18):6076-83
references.pmid: 14522938
references.citation: Proteomics. 2009 Feb;9(4):882-913
references.pmid: 19212958
references.citation: Blood. 2005 May 15;105(10):3939-44
references.pmid: 15671442
references.citation: Science. 2011 Mar 25;331(6024):1565-70
references.pmid: 21436444
references.citation: Arthritis Rheum. 2010 Jun;62(6):1620-9
references.pmid: 20178128
references.citation: Cancer Res. 2005 Jan 15;65(2):650-6
references.pmid: 15695410
references.citation: Ann Rheum Dis. 2010 Jan;69 Suppl 1:i92-96
references.pmid: 19995755
references.citation: Glycoconj J. 1997 Aug;14(5):569-76
references.pmid: 9298689
references.citation: Proteomics. 2009 Sep;9(17):4143-53
references.pmid: 19688751
references.citation: PLoS One. 2011;6(6):e21246
references.pmid: 21731683
references.citation: J Biol Chem. 1983 Oct 10;258(19):11505-9
references.pmid: 6413502
references.citation: Autoimmun Rev. 2007 Mar;6(4):257-9
references.pmid: 17317619
references.citation: J Clin Oncol. 1997 Nov;15(11):3363-7
references.pmid: 9363867
references.citation: J Immunol. 2000 Mar 1;164(5):2619-28
references.pmid: 10679101
references.citation: Pediatr Transplant. 2005 Jun;9(3):408-15
references.pmid: 15910400
references.citation: Prostate. 2004 Jun 1;59(4):440-7
references.pmid: 15065093
references.citation: J Clin Immunol. 2010 May;30 Suppl 1:S9-14
references.pmid: 20480216
references.citation: Biotechnol Prog. 2005 Nov-Dec;21(6):1644-52
references.pmid: 16321047
references.citation: J Biol Chem. 2004 Apr 30;279(18):19122-32
references.pmid: 14970226
references.citation: Cancer Chemother Pharmacol. 2004 Jul;54(1):95-100
references.pmid: 15118836
references.citation: Arthritis Res Ther. 2009;11(6):R193
references.pmid: 20015375
references.citation: Int J Cancer. 2006 Jan 1;118(1):123-8
references.pmid: 16003736
references.citation: Expert Opin Biol Ther. 2007 Sep;7(9):1401-13
references.pmid: 17727329
references.citation: Cancer Immunol Immunother. 2009 Oct;58(10):1535-44
references.pmid: 19562338
references.citation: J Proteome Res. 2009 Feb;8(2):450-6
references.pmid: 18942870
references.citation: Nat Rev Immunol. 2008 Jun;8(6):467-77
references.pmid: 18500231
references.citation: Cancer Lett. 2006 May 8;236(1):64-71
references.pmid: 15992994
references.citation: J Exp Med. 1998 Apr 20;187(8):1349-54
references.pmid: 9547346
references.citation: Hum Immunol. 1999 Jun;60(6):510-5
references.pmid: 10408800
references.citation: Biochem Biophys Res Commun. 2006 Mar 17;341(3):797-803
references.pmid: 16442075
references.citation: Annu Rev Immunol. 2007;25:21-50
references.pmid: 17029568
references.citation: Nature. 2011 Jun 19;475(7354):110-3
references.pmid: 21685887
references.citation: Science. 2008 Apr 18;320(5874):373-6
references.pmid: 18420934
references.citation: Glycoconj J. 1999 Dec;16(12):801-7
references.pmid: 11133020
references.citation: Science. 2006 Aug 4;313(5787):670-3
references.pmid: 16888140
references.citation: Transplantation. 2009 Jul 15;88(1):1-6
references.pmid: 19584672
references.citation: Thorax. 2008 Mar;63(3):228-33
references.pmid: 17932110
references.citation: Cancer. 2010 Apr 1;116(7):1757-66
references.pmid: 20143437
references.citation: Proteomics. 2008 Jul;8(14):2858-71
references.pmid: 18655055
references.citation: Autoimmunity. 1998;28(1):25-30
references.pmid: 9754811
references.citation: Mol Immunol. 2007 Mar;44(7):1524-34
references.pmid: 17045339
references.citation: Pediatr Transplant. 2005 Apr;9(2):155-61
references.pmid: 15787786
references.citation: Glycobiology. 2007 Dec;17(12):1344-56
references.pmid: 17884841
references.citation: Hum Immunol. 2010 Jul;71(7):643-51
references.pmid: 20433885
references.citation: J Gastroenterol Hepatol. 2006 Aug;21(8):1281-5
references.pmid: 16872310
references.citation: Expert Opin Biol Ther. 2006 Nov;6(11):1161-73
references.pmid: 17049014
references.citation: Adv Exp Med Biol. 2008;622:261-71
references.pmid: 18546634
references.citation: Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11810-3
references.pmid: 8524854
references.citation: PLoS One. 2012;7(6):e37243
references.pmid: 22675478
references.citation: Biochim Biophys Acta. 2006 Apr;1760(4):669-77
references.pmid: 16413679
references.citation: J Biol Chem. 2002 Jul 26;277(30):26733-40
references.pmid: 11986321
references.citation: Int J Cancer. 2005 Mar 20;114(2):268-73
references.pmid: 15540228
references.citation: Mol Cancer Ther. 2008 Mar;7(3):449-54
references.pmid: 18319334
references.citation: J Clin Immunol. 2010 May;30 Suppl 1:S15-9
references.pmid: 20390325